Anti-PCI antibody for regulating liver regeneration/repair
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 11, 2011
Grant Date -
Feb 5, 2009
app pub date -
Oct 11, 2005
filing date -
Oct 15, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to uses of PCI, which inhibits HGFa activity, and to uses of anti-PCI antibodies, which neutralize HGFa inhibition; and to agents for regulating and controlling tissue regeneration and/or repair, with PCI as an active ingredient; and to agents for enhancing tissue regeneration and/or repair, with anti-PCI antibodies as active ingredients (particularly, anti-PCI antibodies with the action of neutralizing PCI (anti-PCI neutralizing antibodies)).
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully